Skip to main content
. 2020 Jan 14;11(6):1555–1567. doi: 10.7150/jca.37529

Table 3.

Expression of mutant genes in cell lines

Gene Expression of Cell Line
KRAS Occurred in almost all of the primary tumors of pancreatic cancer, but the BxPC-3 cell line is WT
SMD4/DPC4 Capan-2, MIA PaCa-2, PANC-1, SU.86.86 without SMD4 gene inactivation
TP53 Its mutation occurs in 50% of pancreatic malignant tumors and is associated with late tumor progression
CDKN2A/P16 Basically all pancreatic cancer cell lines have inactivation of the P16 gene